ORAMED PHARMACEUTICALS INC. Business Operations Contracts & Agreements
21 Contracts & Agreements
- Agency Agreements (2 contracts)
- Indemnification Agreements (12)
- Sales Agreements (1)
- Services Agreements (5)
- Termination Agreements (1)
- Mutual Termination and Release Agreement, dated September 21, 2023, by and between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on August 10, 2023)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on March 6, 2023)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on May 12, 2022)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 24, 2021)
- Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of its directors and officers (Filed With SEC on July 14, 2021)
- Clinical Research Organization Services Agreement dated September 16, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC (Filed With SEC on September 18, 2020)
- Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC (Filed With SEC on September 9, 2020)
- Amendment to the Service Agreement, dated January 10, 2020, between KNRY Ltd. and Oramed Ltd (Filed With SEC on April 6, 2020)
- Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on January 9, 2020)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 27, 2019)
- Amendment #1 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC (Filed With SEC on July 10, 2019)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on July 10, 2019)
- Amendment #2 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC (Filed With SEC on July 10, 2019)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 28, 2018)
- Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 29, 2017)
- AMENDMENT NO. 1 TO AT-THE-MARKET ISSUANCE SALES AGREEMENT (Filed With SEC on April 5, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on April 5, 2017)
- PLACEMENT AGENCY AGREEMENT between (Filed With SEC on December 26, 2013)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on July 11, 2013)
- ORAMED PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on November 6, 2008)
